The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: 0.00 (0.00%)
Spread: 0.20 (2.439%)
Open: 8.30
High: 8.30
Low: 8.30
Prev. Close: 8.30
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1H’22 update: strong shipments and cash inflows

20 Oct 2021 07:30

RNS Number : 5881P
CyanConnode Holdings PLC
20 October 2021
 

Hardman & Co Research: 

CyanConnode (CYAN): 1H'22 update: strong shipments and cash inflows

Alongside the multiple new contracts signed in fiscal 1H, CyanConnode's smart meter intelligent module shipments continued to accelerate during the period. 315,000 modules were shipped, versus 92,000 in the same period last year and 481,000 for the entirety of FY'21. 1H'22 revenue came in at £4.1m, almost three times the comparative 1H'21 figure of £1.5m. The potentially immense market opportunity is starting to translate into large orders, accelerating shipment volumes, exceptionally strong revenue growth and cash inflows - £3.8m was received from customers during the period, resulting in £1.7m net cash at end-September 2021. Our updated DCF-implied fair equity value for CyanConnode is £89.6m.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/cyanconnode/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Milan Radia

+44(0)20 3693 7075

 

mr@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZMMGNLFGMZM
Date   Source Headline
15th Sep 20177:01 amRNSProposed Fundraising and Share Consolidation
15th Sep 20177:00 amRNSHalf-year Report
7th Sep 20177:00 amRNSAppointment of Managing Director India
6th Sep 20177:00 amRNSHolding(s) in Company
31st Aug 20174:36 pmRNSTotal Voting Rights
15th Aug 20177:00 amRNSNew $10M Purchase Order Extension in Bangladesh
31st Jul 201712:30 pmRNSTotal Voting Rights
13th Jul 20178:44 amRNSBoard Realignment and Issue of Options
13th Jul 20177:00 amRNSTrading Update
11th Jul 20172:55 pmRNSBlock listing Update
6th Jul 20177:00 amRNS$1.1 million purchase order from India
3rd Jul 20171:30 pmRNSHolding(s) in Company
30th Jun 20179:18 amRNSTotal Voting Rights
27th Jun 20177:00 amRNSDirector Shareholding and Issue of Options
23rd Jun 20177:00 amRNSDirector Shareholding and Issue of Options
22nd Jun 201710:51 amRNSDirector Shareholding and Issue of Options
19th Jun 20177:00 amRNSFollow-on orders for 10,400 smart meters in India
15th Jun 201712:13 pmRNSResult of AGM
15th Jun 20177:00 amRNSContract Award Extension
19th May 20177:00 amRNSChange of Adviser
16th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSTotal Voting Rights
12th Apr 20177:00 amRNSContract Win
10th Apr 20174:50 pmRNSHolding(s) in Company
10th Apr 20174:31 pmRNSHolding(s) in Company
10th Apr 20177:00 amRNSHolding(s) in Company
6th Apr 20179:21 amRNSIssue of Options
6th Apr 20177:00 amRNSDirector Shareholding and Issue of Options
4th Apr 20177:00 amRNSCompletion of Placing and Subscription
3rd Apr 201711:17 amRNSResults of General Meeting
3rd Apr 20177:00 amRNSBoard Changes
17th Mar 201710:36 amRNSResult of Placing and Subscription
17th Mar 20179:00 amRNSProposed £3.2 million fundraise
28th Feb 20177:00 amRNSCyanConnode signs MoU with Tech Mahindra
17th Feb 20173:45 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSNew $5.4 million Purchase Order in Bangladesh
6th Feb 20177:00 amRNSContract Win
31st Jan 20175:00 pmRNSTotal Voting Rights
19th Jan 20177:00 amRNSTrading Update
13th Jan 20177:00 amRNSBlock listing Update
30th Dec 20169:00 amRNSDirector Shareholdings
15th Dec 201610:23 amRNSHolding(s) in Company
8th Dec 20167:00 amRNSContract Wins
5th Dec 20167:00 amRNSThird Smart Metering Order with Larsen & Toubro
1st Dec 201611:20 amRNSHolding(s) in Company
1st Dec 201611:09 amRNSDirector Shareholdings
17th Nov 201610:30 amRNSChange of Company Name and Registered Address
15th Nov 20167:00 amRNSCyanConnode Wins Two Frost & Sullivan Awards
9th Nov 20167:00 amRNSIssue of Equity
1st Nov 20168:57 amRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.